Studies on the development of the charge heterogeneity of the influenza virus glycoproteinsBOSCH, F. X.Archives of virology. 1985, Vol 83, Num 3-4, pp 311-317, issn 0304-8608Article

Cancer incidence correlations : genital, urinary and some tobacco-related cancersBOSCH, F. X; CARDIS, E.International journal of cancer. 1990, Vol 46, Num 2, pp 178-184, issn 0020-7136, 7 p.Article

Black tobacco and cancer : introducing an epidemiological reviewBOSCH, F. X; CARDIS, E.European journal of cancer (1990). 1991, Vol 27, Num 11, pp 1345-1348, issn 0959-8049Article

Epidemiology, Prevention and Treatment of HPV Infections and Related Pathologies in Italy: a Comparison with the International ContextBOSCH, F. X; GASPARINI, Roberto; PANATTO, Donatella et al.Vaccine. 2009, Vol 27, issn 0264-410X, 65 p., SUP1Conference Proceedings

Human papillomavirus and other risk factors for cervical cancer : Virus and cancerBOSCH, F. X; MUNOZ, N; DE SANJOSE, S et al.Biomedicine & pharmacotherapy. 1997, Vol 51, Num 6-7, pp 268-275, issn 0753-3322Article

Expression of cell cycle proteins in head and neck cancer correlates with tumor site rather than tobacco useHAAS, S; HÖRMANN, K; BOSCH, F. X et al.Oral oncology (1997). 2002, Vol 38, Num 6, pp 618-623, issn 1368-8375Article

HPV and cervical cancer : screening or vaccination?BOSCH, F. X; CASTELISAGUE, X; DE SANJOSE, S et al.British journal of cancer. 2008, Vol 98, Num 1, pp 15-21, issn 0007-0920, 7 p.Article

HPV vaccines and cervical cancerBOSCH, F. X.Annals of oncology. 2008, Vol 19, issn 0923-7534, v48-v51, SUP5Conference Paper

Gentherapie mit p53-Tumorsuppressorgen = Gene therapy with p53 tumor suppressorsDIETZ, A; ESSER, D; HELBIG, M et al.HNO. Hals-, Nasen-, Ohrenärzte. 2003, Vol 51, Num 5, pp 365-368, issn 0017-6192, 4 p.Article

Speichelgangzyste der Parotis und Adenokarzinom = Parotid gland cysts and adenocarcinomaSCHWETSCHKE, O; ZIMMERER, A; BOSCH, F. X et al.HNO. Hals-, Nasen-, Ohrenärzte. 1994, Vol 42, Num 7, pp 441-445, issn 0017-6192Article

A breast cancer case-control study in Girona, Spain. Endocrine, familial and lifestyle factorsVILADIU, P; IZQUIERDO, A; DE SANJOSE, S et al.European journal of cancer prevention. 1996, Vol 5, Num 5, pp 329-335, issn 0959-8278Conference Paper

The role of HPV in the etiology of cervical cancerMUNOZ, N; BOSCH, F. X; DE SANJOSE, S et al.Mutation research. 1994, Vol 305, Num 2, pp 293-301, issn 0027-5107Article

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15―25 years with and without serological evidence of previous exposure to HPV-16/18SZAREWSKI, A; POPPE, W. A. J; CASTELLSAGUE, X et al.International journal of cancer (Print). 2012, Vol 131, Num 1, pp 106-116, issn 0020-7136, 11 p.Article

Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countriesLOUIE, K. S; DE SANJOSE, S; DIAZ, M et al.British journal of cancer. 2009, Vol 100, Num 7, pp 1191-1197, issn 0007-0920, 7 p.Article

Comparison of pI6^INK4a expression with p53 alterations in head and neck cancer by tissue microarray analysisKARSAI, S; ABEL, U; ROESCH-ELY, M et al.Journal of pathology. 2007, Vol 211, Num 3, pp 314-322, issn 0022-3417, 9 p.Article

Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancerROESCH-ELY, M; NEES, M; BOSCH, F. X et al.Oncogene (Basingstoke). 2007, Vol 26, Num 1, pp 54-64, issn 0950-9232, 11 p.Article

Increased rectal cell proliferation following alcohol abuseSIMANOWSKI, U. A; HOMANN, N; KNÜHL, M et al.Gut. 2001, Vol 49, Num 3, pp 418-422, issn 0017-5749Article

Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinomaYEPING SUN; ELUF-NETO, J; BOSCH, F. X et al.Cancer epidemiology, biomarkers & prevention. 1999, Vol 8, Num 10, pp 935-940, issn 1055-9965Article

Correlation between the presence of anti HPV33 VLP antibodies and HPV DNA in cervical neoplasia patientsHAMSIKOVKA, E; SMAHEL, M; SAPP, M et al.Archives of virology. 1997, Vol 142, Num 2, pp 413-416, issn 0304-8608Article

Serological response to HPV16 in CIN-III and cervical-cancer patients. Case-control studies in Spain and ColombiaDE SANJOSE, S; HAMSIKOVA, E; MUNOZ, M. T et al.International journal of cancer. 1996, Vol 66, Num 1, pp 70-74, issn 0020-7136Article

Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Columbia and SpainNONNENMACHER, B; HUBBERT, N. L; KIRNBAUER, R et al.The Journal of infectious diseases. 1995, Vol 172, Num 1, pp 19-24, issn 0022-1899Article

Serologic response in human papillomavirus-associated invasive cervical cancerVISCIDI, R. P; SUN, Y; TSUZAKI, B et al.International journal of cancer. 1993, Vol 55, Num 5, pp 780-784, issn 0020-7136Article

Risk factors for cervical cancer in Colombia and SpainBOSCH, F. X; MUNOZ, N; TAFUR, L et al.International journal of cancer. 1992, Vol 52, Num 5, pp 750-758, issn 0020-7136Article

Two genetically defined trans-acting loci coordinately regulate overlapping sets of liver-specific genesRUPPERT, S; BOSHART, M; BOSCH, F. X et al.Cell (Cambridge). 1990, Vol 61, Num 5, pp 895-904, issn 0092-8674, 10 p.Article

Anti-HPV vaccination: A review of recent economic data for ItalyMENNINI, F. S; COSTA, S; FAVATO, G et al.Vaccine. 2009, Vol 27, issn 0264-410X, A54-A61, SUP1Conference Paper